ASX - By Stock
|
NTI |
Re:
Ann: Neurotech Receives $10 Million in Placement Funds
|
|
ma420
|
3 |
717 |
0 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
3
|
717
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
ma420
|
122 |
25K |
1 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
122
|
25K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
ma420
|
122 |
25K |
0 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
122
|
25K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
ma420
|
122 |
25K |
1 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
122
|
25K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
ma420
|
122 |
25K |
2 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
122
|
25K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
ma420
|
122 |
25K |
2 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
122
|
25K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
ma420
|
122 |
25K |
5 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
122
|
25K
|
5
|
|
ASX - By Stock
|
DXB |
Re:
Dimerix (ASX: DXB) Discussion Thread
|
|
ma420
|
626 |
196K |
3 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
626
|
196K
|
3
|
|
ASX - By Stock
|
DXB |
Re:
Dimerix (ASX: DXB) Discussion Thread
|
|
ma420
|
626 |
196K |
1 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
626
|
196K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Dimerix (ASX: DXB) Discussion Thread
|
|
ma420
|
626 |
196K |
1 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
626
|
196K
|
1
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Successful Completion of Retail Entitlement Offer
|
|
ma420
|
5 |
1.3K |
9 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
5
|
1.3K
|
9
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
ma420
|
330 |
90K |
5 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
330
|
90K
|
5
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
ma420
|
330 |
90K |
9 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
330
|
90K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
ma420
|
232 |
50K |
1 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
232
|
50K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
ma420
|
232 |
50K |
2 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
232
|
50K
|
2
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
ma420
|
330 |
90K |
10 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
330
|
90K
|
10
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
ma420
|
10K |
3.7M |
5 |
23/04/24 |
23/04/24 |
General
|
10K
|
3.7M
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
ma420
|
232 |
50K |
8 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
232
|
50K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
ma420
|
232 |
50K |
5 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
232
|
50K
|
5
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
ma420
|
10K |
3.7M |
20 |
23/04/24 |
23/04/24 |
General
|
10K
|
3.7M
|
20
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
ma420
|
10K |
3.7M |
10 |
23/04/24 |
23/04/24 |
General
|
10K
|
3.7M
|
10
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
ma420
|
20K |
6.9M |
7 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
20K
|
6.9M
|
7
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
ma420
|
2.0K |
668K |
7 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
2.0K
|
668K
|
7
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
ma420
|
10K |
3.7M |
7 |
19/04/24 |
19/04/24 |
General
|
10K
|
3.7M
|
7
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Clarity launches $121 million equity raise
|
|
ma420
|
87 |
29K |
6 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
87
|
29K
|
6
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
ma420
|
330 |
90K |
4 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
330
|
90K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
ma420
|
122 |
25K |
12 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
122
|
25K
|
12
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
ma420
|
122 |
25K |
14 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
122
|
25K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust makes Head of Manufacturing appointment
|
|
ma420
|
37 |
8.6K |
5 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
37
|
8.6K
|
5
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Clarity launches $121 million equity raise
|
|
ma420
|
87 |
29K |
7 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
87
|
29K
|
7
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Trading Halt
|
|
ma420
|
86 |
18K |
0 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
86
|
18K
|
0
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust makes Head of Manufacturing appointment
|
|
ma420
|
37 |
8.6K |
22 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
37
|
8.6K
|
22
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust makes Head of Manufacturing appointment
|
|
ma420
|
37 |
8.6K |
28 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
37
|
8.6K
|
28
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Trading Halt
|
|
ma420
|
86 |
18K |
2 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
86
|
18K
|
2
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Trading Halt
|
|
ma420
|
86 |
18K |
3 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
86
|
18K
|
3
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Trading Halt
|
|
ma420
|
86 |
18K |
1 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
86
|
18K
|
1
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Trading Halt
|
|
ma420
|
86 |
18K |
2 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
86
|
18K
|
2
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Trading Halt
|
|
ma420
|
86 |
18K |
3 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
86
|
18K
|
3
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Investor Webinar on Clinical Trial Results
|
|
ma420
|
3 |
1.0K |
2 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
3
|
1.0K
|
2
|
|
ASX - By Stock
|
AS2 |
Re:
Ann: Askari Defines Maiden Mineral Resource at Burracoppin Gold
|
|
ma420
|
19 |
3.5K |
7 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
19
|
3.5K
|
7
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
ma420
|
20K |
6.9M |
11 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
20K
|
6.9M
|
11
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
ma420
|
20K |
6.9M |
5 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
20K
|
6.9M
|
5
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
ma420
|
20K |
6.9M |
12 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
20K
|
6.9M
|
12
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
73 |
23K |
3 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
73
|
23K
|
3
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
73 |
23K |
5 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
73
|
23K
|
5
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
ma420
|
272 |
83K |
13 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
272
|
83K
|
13
|
|
ASX - By Stock
|
RAC |
Re:
Race options thread
|
|
ma420
|
821 |
207K |
2 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
821
|
207K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Race options thread
|
|
ma420
|
821 |
207K |
1 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
821
|
207K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Final Ethics Approval for Open-Label MND Extension Study
|
|
ma420
|
77 |
18K |
8 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
77
|
18K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Final Ethics Approval for Open-Label MND Extension Study
|
|
ma420
|
77 |
18K |
10 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
77
|
18K
|
10
|
|